Diagnostic immunohistology of muscle diseases

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 3, 2005, Pages 181-193

  Vogel, Hannes ^a,c   Zamecnik, Josef ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Laboratory of Neuropathology   (United States)

Author keywords

Congenital myopathies; Immunohistochemistry; Inflammatory myopathies; Muscular dystrophies; Skeletal muscle

Indexed keywords

ACTIN; ADHALIN; ALPHA ACTININ; CALPAIN 3; CAVEOLIN 3; COLLAGEN TYPE 6; CONNECTIN; CYTOSKELETON PROTEIN; DESMIN; DYSFERLIN; DYSTROGLYCAN; DYSTROPHIN; EMERIN; LAMIN A; LAMIN C; LAMININ; MYOSIN; PERLECAN; SARCOGLYCAN;

BECKER MUSCULAR DYSTROPHY; CELL NUCLEUS MEMBRANE; DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; EXTRACELLULAR MATRIX; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENETIC ANALYSIS; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LIMB GIRDLE MUSCULAR DYSTROPHY; MITOCHONDRION; MIYOSHI MYOPATHY; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE FIBRIL; MUSCULAR DYSTROPHY; MYOPATHY; MYOSITIS; NEMALINE MYOPATHY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SARCOLEMMA; SCHWARTZ JAMPEL SYNDROME; SKELETAL MUSCLE; WESTERN BLOTTING;

EID: 15244360091     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/64.3.181     Document Type: Review

References (78)

1. Sewry CA, Dubowitz V. Histochemistry and immunocytochemistry of muscle in health and disease. In: Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of Voluntary Muscle, 7th ed. New York: Cambridge University Press, 2001:257
2. Pegoraro E, Mancias P, Swerdlow SH, et al. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol 1996;40:782-91
3. Marbini A, Bellanova MF, Ferrari A, et al. Immunohistochemical study of merosin-negative congenital muscular dystrophy: Laminin alpha 2 deficiency in skin biopsy. Acta Neuropathol (Berl) 1997;94:103-8
4. Cohn RD, Hermann R, Sorokin L, et al. Laminin alpha2 chain-deficient congenital muscular dystrophy: Variable epitope expression in severe and mild cases. Neurology 1998;51:94-100
5. Cohn RD, Herrmann R, Wewer UM, et al. Changes of laminin beta 2 chain expression in congenital muscular dystrophy. Neuromuscul Disord 1997;7:373-78
6. Hodges BL, Hayashi YK, Nonaka I, et al. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J Cell Sci 1997;110 (Pt 22):2873-81
7. Brockington M, Blake DJ, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001;69:1198-209
8. Jimenez-Mallebrera C, Torelli S, Brown SC, et al. Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome. Eur J Paediatr Neurol 2003;7:129-37
9. Poppe M, Cree L, Bourke J, et al. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 2003;60:1246-51
10. Hoffman EP, Pegoraro E. Collagen VI gene mutations: Bethlem myopathy/limb-girdle muscular dystrophy. In: Karpati G, ed. Structural and Molecular Basis of Skeletal Muscle Diseases. Basel: ISN Neuropath Press, 2002:42
11. Merlini L, Villanova M, Sabatelli P, et al. Decreased expression of laminin beta 1 in chromosome 21-linked Bethlem myopathy. Neuromuscul Disord 1999;9:326-29
12. Morandi L, Barresi R, Di Blasi C, et al. Clinical heterogeneity of adhalin deficiency. Ann Neurol 1996;39:196-202
13. Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 2004;62:620-23
14. Voit T, Tome FMS. The congenital muscular dystrophies. In: Engel AG, Franzini-Armstrong C, eds. Myology, vol. 2. New York: McGraw-Hill, 2004:1230
15. Brockington M, Brown SC, Lampe A, et al. Prenatal diagnosis of Ullrich congenital muscular dystrophy using haplotype analysis and collagen VI immunocytochemistry. Prenat Diagn 2004;24:440-44
16. Nicholson LV, Johnson MA, Gardner-Medwin D, et al. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (Berl) 1990;80:239-50
17. Hoffman EP. Dystrophinopathies. In: Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of Voluntary Muscle, 7th ed. New York: Cambridge University Press, 2001:385-432
18. Hu XY, Ray PN, Murphy EG, et al. Duplicational mutation at the Duchenne muscular dystrophy locus: Its frequency, distribution, origin, and phenotype-genotype correlation. Am J Hum Genet 1990;46:682-95
19. Heckel S, Favre R, Flori J, et al. In utero fetal muscle biopsy: A precious aid for the prenatal diagnosis of Duchenne muscular dystrophy. Fetal Diagn Ther 1999;14:127-32
20. Niiyama T, Higuchi I, Sakoda S, et al. Diagnosis of dystrophinopathy by skin biopsy. Muscle Nerve 2002;25:398-401
21. Arahata K, Beggs AH, Honda H, et al. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J Neurol Sci 1991;101:148-56
22. Anderson LVB. Dystrophinopathies. In: Karpati G, ed. Structural and Molecular Basis of Skeletal Muscle Diseases. Basel: ISN Neuropath Press, 2002:6-23
23. Nicholson LV, Johnson MA, Bushby KM, et al. Functional significance of dystrophin positive fibers in Duchenne muscular dystrophy. Arch Dis Child 1993;68:632-36
24. Fanin M, Freda MP, Vitiello L, et al. Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: Threshold effect for deletion size? Muscle Nerve 1996;19:1154-60
25. Nguyen TM, Morris GE. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy. Am J Hum Genet 1993;52:1057-66
26. Nicholson LV, Johnson MA, Bushby KM, et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathologic data. Part 2. Correlations within individual patients. J Med Genet 1993;30:737-44
27. Hoffman EP, Rao D, Pachman LM. Clarifying the boundaries between the inflammatory and dystrophic myopathies: Insights from molecular diagnostics and microarrays. Rheum Dis Clin North Am 2002;28:743-57
28. Pegoraro E, Schimke RN, Garcia C, et al. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: Evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology 1995;45:677-90
29. Matsumura K, Nonaka I, Tome FM, et al. Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having inframe deletions in the rod domain of dystrophin. Am J Hum Genet 1993;53:409-16
30. Matsumura K, Tome FM, Ionasescu V, et al. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J Clin Invest 1993;92:866-71
31. Draviam R, Billington L, Senchak A, et al. Confocal analysis of the dystrophin protein complex in muscular dystrophy. Muscle Nerve 2001;24:262-72
32. Helliwell TR, Man NT, Morris GE, et al. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibers in dystrophies and inflammatory myopathies. Neuromuscul Disord 1992;2:177-84
33. Sewry CA, Clerk A, Heckmatt JZ, et al. Dystrophin abnormalities in polymyositis and dermatomyositis. Neuromuscul Disord 1991;1:333-39
34. Hayashi YK, Ogawa M, Tagawa K, et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 2001;57:115-21
35. Carpenter S, Karpati G. Genetic Diseases of Muscle: Diseases of Skeletal Muscle, 2nd ed. New York: Oxford University Press, 2001:446
36. Zatz M, Vainzof M, Passos-Bueno MR. Limb-girdle muscular dystrophy: One gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol 2000;13:511-17
37. Moore S, Shilling C, Westra S, et al. Limb-girdle muscular dystrophy in the USA: Distribution of immunophenotypes and genotypes from an ongoing multicenter collaborative study. J Neuropathol Exp Neurol 2004;63:532
38. Bonnemann CG, Wong J, Jones KJ, et al. Primary gamma-sarcoglycanopathy (LGMD 2C): Broadening of the mutational spectrum guided by the immunohistochemical profile. Neuromuscul Disord 2002;12:273-80
39. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20:31-36
40. Anderson LV, Davison K, Moss JA, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999;8:855-61
41. Ho M, Amato A, Brown RH. Dysferlinopathies. In: Karpati G, ed. Structural and Molecular Basis of Skeletal Muscle Diseases. Basel: ISN Neuropath Press, 2002:30
42. Chrobakova T, Hermanova M, Kroupova II, et al. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome. Neuromuscul Disord 2004;14:659-65
43. Gallardo E, Rojas-Garcia R, de Luna N, et al. Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients. Neurology 2001;57:2136-38
44. Woodman SE, Sotgia F, Galbiati F, et al. Caveolinopathies: Mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 2004;62:538-43
45. Goebel HH, Anderson JR, Hubner C, et al. Congenital myopathy with excess of thin myofilaments. Neuromuscul Disord 1997;7:160-68
46. Yamaguchi M, Robson RM, Stromer MH, et al. Nemaline myopathy rod bodies: Structure and composition. J Neurol Sci 1982;56:35-56
47. Goebel HH. Congenital myopathies at their molecular dawning. Muscle Nerve 2003;27:527-48
48. North K. Congenital Myopathies. In: Engel AG, Franzini-Armstrong C, eds. Myology, vol. 2, 3rd ed. New York: McGraw-Hill, 2004:1486
49. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004;62:1363-71
50. Hauser MA, Horrigan SK, Salmikangas P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet 2000;9:2141-47
51. Moreira ES, Wiltshire TJ, Faulkner G, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000;24:163-66
52. Serrano AL, Perez M, Lucia A, et al. Immunolabeling, histochemistry and in situ hybridisation in human skeletal muscle fibers to detect myosin heavy chain expression at the protein and mRNA level. J Anat 2001;199:329-37
53. Larsson L, Li X, Edstrom L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels. Crit Care Med 2000;28:34-45
54. Gerull B, Gramlich M, Atherton J, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002;30:201-4
55. Hackman P, Vihola A, Haravuori H, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002;71:492-500
56. Udd B. Limb-girdle type muscular dystrophy in a large family with distal myopathy: Homozygous manifestation of a dominant gene? J Med Genet 1992;29:383-89
57. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;81:27-40
58. Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: From LGMD2A to LGMD2G. Am J Med Genet 1999;82:392-98
59. Richard I, Roudaut C, Saenz A, et al. Calpainopathy - a survey of mutations and polymorphisms. Am J Hum Genet 1999;64:1524-40
60. Anderson LV, Davison K, Moss JA, et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol 1998;153:1169-79
61. Vainzof M, Anderson LV, McNally EM, et al. Dysferlin protein analysis in limb-girdle muscular dystrophies. J Mol Neurosci 2001;17:71-80
62. Bushby KM, Beckmann JS. The 105th ENMC sponsored workshop: Pathogenesis in the nonsarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002. Neuromuscul Disord 2003;13:80-90
63. Haravuori H, Vihola A, Straub V, et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: Titin is the candidate gene. Neurology 2001;56:869-77
64. Selcen D, Ohno K, Engel AG. Myofibrillar myopathy: Clinical, morphologic and genetic studies in 63 patients. Brain 2004;127:439-51
65. Manilal S, Sewry CA, Man N, et al. Diagnosis of X-linked Emery-Dreifuss muscular dystrophy by protein analysis of leukocytes and skin with monoclonal antibodies. Neuromuscul Disord 1997;7:63-66
66. Sabatelli P, Squarzoni S, Petrini S, et al. Oral exfoliative cytology for the noninvasive diagnosis in X-linked Emery-Dreifuss muscular dystrophy patients and carriers. Neuromuscul Disord 1998;8:67-71
67. Sewry CA, Brown SC, Mercuri E, et al. Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations. Neuropathol Appl Neurobiol 2001;27:281-90
68. Bornemann A, Anderson LV. Diagnostic protein expression in human muscle biopsies. Brain Pathol 2000;10:193-214
69. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995;37(suppl 1):74-86
70. Spuler S, Engel AG. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies. Neurology 1998;50:41-46
71. Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 2002;28:779-98
72. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988;23:64-72
73. Nyberg P, Wikman AL, Nennesmo I, et al. Increased expression of interleukin 1 alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000;27:940-48
74. Askanas V, Engel WK, Mirabella M. Idiopathic inflammatory myopathies: Inclusion-body myositis, polymyositis, and dermatomyositis. Curr Opin Neurol 1994;7:448-56
75. Rahman S, Lake BD, Taanman JW, et al. Cytochrome oxidase immunohistochemistry: Clues for genetic mechanisms. Brain. 2000;123(Pt 3):591-600
76. Paulus W, Lehr A, Peiffer J, et al. Immunohistochemical demonstration of mitochondria in routinely processed tissue using a monoclonal antibody. J Pathol 1990;160:321-28
77. Cashman NR, Covault J, Wollman RL, et al. Neural cell adhesion molecule in normal, denervated, and myopathic human muscle. Ann Neurol 1987;21:481-89
78. Gattenlohner S, Schneider C, Thamer C, et al. Expression of fetal type acetylcholine receptor is restricted to type 1 muscle fibers in human neuromuscular disorders. Brain 2002;125:1309-19